What clinical features should prompt me to suspect Neuromyelitis Optica Spectrum Disorder (NMOSD) in a patient?
22 Aug 2025View Answer →
clinical q&a library
Explore a database of clinical questions answered by iatroX, referencing established clinical guidelines, SmPCs, and peer-reviewed literature.
What role does pharmacotherapy play in the management of Antisocial Personality Disorder, and what medications are commonly used?
Role of pharmacotherapy in antisocial personality disorder (ASPD): Pharmacological interventions are not routinely recommended...
22 Aug 2025View Answer →
When should I consider referring a patient with Antisocial Personality Disorder to mental health services?
Consider referring a patient with antisocial personality disorder to mental health services when there is a need for comprehensive assessment of antisocial b...
22 Aug 2025View Answer →
What are the recommended management strategies for patients with Antisocial Personality Disorder in primary care?
In primary care, management strategies for patients with antisocial personality disorder include actively engaging the individual in treatment and avoiding e...
22 Aug 2025View Answer →
How can I differentiate between Antisocial Personality Disorder and other personality disorders in a primary care setting?
To differentiate Antisocial Personality Disorder (ASPD) from other personality disorders in a primary care setting, focus on the following key clinic...
22 Aug 2025View Answer →
What are the key diagnostic criteria for Antisocial Personality Disorder according to the DSM-5?
The key diagnostic criteria for Antisocial Personality Disorder (ASPD) according to the DSM-5 include a pervasive pattern of disregard for and violat...
22 Aug 2025View Answer →
What monitoring parameters should be established for a patient recovering from NMS after discontinuation of antipsychotic medication?
After discontinuation of antipsychotic medication due to neuroleptic malignant syndrome (NMS), monitoring should focus on both physical and mental he...
22 Aug 2025View Answer →
When should I consider referring a patient with NMS to secondary care for further management?
Consider referring a patient with neuroleptic malignant syndrome (NMS) to secondary care urgently if they present with severe symptoms or complicatio...
22 Aug 2025View Answer →
What immediate management steps should be taken for a patient diagnosed with NMS in a primary care setting?
Immediate management of neuroleptic malignant syndrome (NMS) in a primary care setting involves urgent recognition, cessation of all neuroleptic or d...
22 Aug 2025View Answer →
What are the key clinical features to recognize Neuroleptic Malignant Syndrome (NMS) in a patient on antipsychotic medication?
Key clinical features to recognize Neuroleptic Malignant Syndrome (NMS) in a patient receiving antipsychotic medication include:...
22 Aug 2025View Answer →
What are the current guidelines for managing pain and other symptoms associated with neurofibromas in patients with NF1?
Management of pain and symptoms associated with neurofibromas in neurofibromatosis type 1 (NF1) primarily involves a comprehensive assessmen...
22 Aug 2025View Answer →
When should I consider referring a patient with Neurofibromatosis for specialist assessment or management?
Consider referring a patient with neurofibromatosis for specialist assessment or management if they present with complications or symptoms suggestive...
22 Aug 2025View Answer →
What are the recommended surveillance protocols for patients with Neurofibromatosis to monitor for complications?
Recommended surveillance protocols for patients with Neurofibromatosis to monitor for complications include:Regular clinical rev...
22 Aug 2025View Answer →
How should I approach the genetic testing and counselling for a patient with a family history of Neurofibromatosis?
Approach to Genetic Testing and Counselling for Neurofibromatosis Family HistoryReferral to Specialist Genetics Service:...
22 Aug 2025View Answer →
What are the key clinical features that differentiate Neurofibromatosis Type 1 (NF1) from Neurofibromatosis Type 2 (NF2)?
Neurofibromatosis Type 1 (NF1) primarily presents with multiple café-au-lait macules, axillary or inguinal freckling, Lisch nodules (iris ha...
22 Aug 2025View Answer →
How can I interpret the results of nerve conduction studies to differentiate between peripheral neuropathy and radiculopathy?
Interpreting nerve conduction studies (NCS) to differentiate peripheral neuropathy from radiculopathy involves assessing the pattern and location of ...
22 Aug 2025View Answer →
What are the key indications for referring a patient for nerve conduction studies (NCS) and electromyography (EMG) in primary care?
Key indications for referring a patient from primary care for nerve conduction studies (NCS) and electromyography (EMG) include clinical features suggestive ...
22 Aug 2025View Answer →
What criteria should I use to decide when to refer a newborn with respiratory distress to a neonatal unit?
Criteria for referring a newborn with respiratory distress to a neonatal unit include:Presence of severe respiratory distress si...
22 Aug 2025View Answer →
How can I differentiate between physiological and pathological weight loss in the first week of life for a newborn infant?
Physiological weight loss in a newborn during the first week of life is common and usually relates to body fluid adjustments. It typically i...
22 Aug 2025View Answer →
What are the recommended guidelines for screening and managing congenital hypothyroidism in newborns?
Screening for congenital hypothyroidism in newborns is typically performed through newborn bloodspot screening, which is standard practice i...
22 Aug 2025View Answer →